Boehringer Ingelheim, a global leader in animal health, has launched NexGard SPECTRA® (afoxolaner and milbemycin oxime) in India after approval from the Central Drugs Standard Control Organisation. This represents an expansion of their successful NexGard® product line for dogs aged two months and above, weighing at least one pound. NexGard...